Type Whole antibody Target FAP CAS Number 216669-97-5 | Source Humanized (from mouse) ATC code none ChemSpider none | |
How to pronounce sibrotuzumab
Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP
In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.
References
Sibrotuzumab Wikipedia(Text) CC BY-SA